Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis

The advent of immune checkpoint inhibitors (ICIs) has significantly improved cancer treatment. With the increasing use of ICIs, ICI-related myocarditis has been recognized. However, an evidence-based therapeutic strategy has not been established because of the limited knowledge on ICI-related myocarditis. Here, we present four cases of ICI-related fulminant myocarditis (FM). Three of the four cases resulted in fatal outcomes despite aggressive treatment with mechanical circulatory support and immunosuppressive therapy with corticosteroids. Given the poor prognosis of ICI-FM, the establishment of rapid and adequate therapeutic interventions on the basis of clinical and pathological evaluation is imperative.

Authors

Institutions

Publication Details

Journal
Cardio-Oncology
Published
2024-11-21
DOI
https://doi.org/10.1186/s40959-024-00288-0
Citations
5
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis

Takeshi Iwasaki, Shouji Matsushima, Kohtaro Abe, Shintaro Kinugawa et al.
5 citations
Cardio-Oncology
Cancer Immunotherapy and Biomarkers
1.41
article

Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis

Takeshi Iwasaki, Shouji Matsushima, Kohtaro Abe, Shintaro Kinugawa, Kayo Misumi, Shunsuke Katsuki, Mikiko Hashisako, Yuki Tateishi, Keisuke Shinohara, Hiroshi Kisanuki, Takeo Fujino, Yoshinao Oda, Soshun Asakawa, Kazuya Hosokawa, Toru Hashimoto, Shoei Yamamoto, Taro Mori, Kei Ikuta, Ryo Izumi, Wataru Otsuru
article en
5 citations

Abstract

The advent of immune checkpoint inhibitors (ICIs) has significantly improved cancer treatment. With the increasing use of ICIs, ICI-related myocarditis has been recognized. However, an evidence-based therapeutic strategy has not been established because of the limited knowledge on ICI-related myocarditis. Here, we present four cases of ICI-related fulminant myocarditis (FM). Three of the four cases resulted in fatal outcomes despite aggressive treatment with mechanical circulatory support and immunosuppressive therapy with corticosteroids. Given the poor prognosis of ICI-FM, the establishment of rapid and adequate therapeutic interventions on the basis of clinical and pathological evaluation is imperative.

Cardio-OncologyVol. 10(1)
Kyushu University (JP), Kyushu University Hospital (JP)
Zero hunger
Openalex Percentile: Top 15%
Cancer Immunotherapy and Biomarkers
1.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.